Wed, September 7, 2022
Tue, September 6, 2022
Mon, September 5, 2022
Fri, September 2, 2022
Thu, September 1, 2022
Wed, August 31, 2022
Tue, August 30, 2022
Mon, August 29, 2022
Sun, August 28, 2022
Fri, August 26, 2022
Thu, August 25, 2022
Wed, August 24, 2022
Tue, August 23, 2022

Vikram Purohit Maintained (AXSM) at Hold with Increased Target to $75 on, Aug 30th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-75-on-aug-30th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Increased Target from $55 to $75 on, Aug 30th, 2022.

Vikram has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Vikram


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
  • Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $49 on, Tuesday, May 3rd, 2022

Publication Contributing Sources